VHL and neoplasm: The tumor suppressor E3 ligase von Hippel-Lindau (VHL), which is widely involved in tumor vascularization, interacts with HIF-1α in a proline hydroxylation-dependent manner and mediates its degradation, thereby inhibiting tumor growth (Fig. 2c).194